share_log

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Amman Bradford K.

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Amman Bradford K.

Vivos Therapeutics | 4:持股變動聲明-高管 Amman Bradford K.
美股SEC公告 ·  2024/11/27 16:48

Moomoo AI 已提取核心訊息

Amman Bradford K., the CFO of Vivos Therapeutics, reported holding 80 shares of the company's common stock as of 11/26/2024. The shares are held directly by Bradford, with no indirect holdings reported. This transaction status is completed, and the shares are classified as non-derivative securities.The announcement does not indicate any recent buying or selling activity, suggesting that the holding quantity remains unchanged. Investors may interpret this as a sign of stability in the executive's position regarding the company's stock. The report provides no additional details on transaction prices or total stock value, focusing solely on the current shareholding status.
Amman Bradford K., the CFO of Vivos Therapeutics, reported holding 80 shares of the company's common stock as of 11/26/2024. The shares are held directly by Bradford, with no indirect holdings reported. This transaction status is completed, and the shares are classified as non-derivative securities.The announcement does not indicate any recent buying or selling activity, suggesting that the holding quantity remains unchanged. Investors may interpret this as a sign of stability in the executive's position regarding the company's stock. The report provides no additional details on transaction prices or total stock value, focusing solely on the current shareholding status.
Vivos Therapeutics首席財務官安曼·布拉德福德報告稱,截至2024年11月26日,該公司持有80股普通股。這些股票由布拉德福德直接持有,未報告間接持股。該交易狀態已完成,股票被歸類爲非衍生證券。該公告並未表明最近有任何買入或賣出活動,表明持有量保持不變。投資者可能會將其解釋爲高管對公司股票的立場穩定的標誌。該報告沒有提供有關交易價格或總股票價值的更多細節,僅關注當前的股權狀況。
Vivos Therapeutics首席財務官安曼·布拉德福德報告稱,截至2024年11月26日,該公司持有80股普通股。這些股票由布拉德福德直接持有,未報告間接持股。該交易狀態已完成,股票被歸類爲非衍生證券。該公告並未表明最近有任何買入或賣出活動,表明持有量保持不變。投資者可能會將其解釋爲高管對公司股票的立場穩定的標誌。該報告沒有提供有關交易價格或總股票價值的更多細節,僅關注當前的股權狀況。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息